Navigation Links
MDOUTLOOK® 4th Annual Quick Polls From ASCO 2011: Report on Clinical Impact of New Developments in Cancer Therapeutics
Date:6/21/2011

ATLANTA, June 21, 2011 /PRNewswire/ -- MDOUTLOOK®, the global oncology intelligence initiative powered by The Arcas Group, announced results from 4th Annual Quick Poll research launched immediately following this month's annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. These Quick Polls expand on previous Quick Polls carried out after the past 3 ASCO annual meetings, as well as similar efforts after the American Society of Hematology (ASH) annual meetings and the San Antonio Breast Cancer Symposium (SABCS).

(Logo: http://photos.prnewswire.com/prnh/20110621/CL23812LOGO)

Within one week, 515 cancer treaters in 38 countries responded to 4 individual Quick Polls on melanoma, non-small cell lung cancer (NSCLC), gastrointestinal (GI) cancers and genitourinary (GU) cancers. This is the first market feedback available post-ASCO. Some of the highlights from this significant research study include:

  • News from ASCO impacts the entire oncology community. A wide variety of sources are used to learn about the important news from this conference.
  • The novel targeted agents vemurafenib and ipilimumab will become the standards of care for malignant melanoma. More than half of all patients with malignant melanoma are expected to receive one if not both of these agents.
  • Physicians are excited about the identification of specific NSCLC patient subpopulations who will respond to crizotinib, erlotinib, or MetMab.
  • Following their recent regulatory approvals, worldwide use of everolimus and sunitinib for pancreatic neuroendocrine tumors (PNET) will greatly increase.
  • There is not a consistent approach to the continued use of anti-angiogenic therapy after progression in stage IV colorectal cancer. Physicians are eagerly awaiting the results of definitive clinical trials which are due in the near future.
  • Axitinib is expected to be the most common 2nd line thera
    '/>"/>

SOURCE The Arcas Group, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Spherix Announces Annual Shareholders Meeting Date
2. Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting
3. MacuCLEAR, Inc. to Present at OneMedForum New York 2011 and at the 2011 BIO Business Forum During the Annual BIO International Convention in Washington, D.C.
4. NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society
5. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
6. Generex Announces Results of Annual Stockholders Meeting
7. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
8. Masimo to Present at William Blair & Company 31st Annual Growth Stock Conference
9. IDEXX Laboratories to Present at William Blair 31st Annual Growth Stock Conference
10. Amylin Pharmaceuticals to Present at Goldman Sachs 32nd Annual Global Healthcare Conference and Jefferies Global Life Sciences Conference
11. Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... The Formulate Fusion Fabric Display ... and marketing teams looking for a fully-functional package for their ... “everything you’ll need to put together a stunning and eye-catching ... a number of displays and accessories that can be quickly ... 20 feet in size. These components vary from kit to ...
(Date:5/20/2013)... -- , Collaboration with the U.S. ... in treatment of mastitis , Major ... begin in the second half 2013 ... Limited (ASX: POH, OTCQX: PPGNY) will collaborate with ... (ARS) to develop and trial products targeting the serious ...
(Date:5/20/2013)... Pa (PRWEB) May 20, 2013 Oven ... with ramp/soak capabilities. The 5R6-900 benchtop controller has ... the device can be plugged into the wall as ... power supply. This distinctive detail makes the device unique, ... , The laboratory temperature controller can also be used ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
... Importance of Allergy Testing in Managing Chronic ... ... Phadia US Inc. announced today,that The National Asthma Education and Prevention ... for the Diagnosis and,Management of Asthma. Information in the guidelines reported ...
... steps ... towards public reporting status., SAN ANTONIO, Aug. 30 ... targeted cancer therapies with improved efficacy and reduced toxicity,announced the ... a control position in a public reporting shell company. ...
... Aug. 30 Pressure,BioSciences, Inc. (Nasdaq: ... has been,issued its first patent by the ... Biomolecular Complexes" (Number,2,259,318), this issuance extends the ... patents previously issued in the United States,Japan, ...
Cached Biology Technology:Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management 2OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company 2Pressure BioSciences, Inc. Issued First Patent in Canada 2Pressure BioSciences, Inc. Issued First Patent in Canada 3
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... Royal Philips Electronics (NYSE: PHG, AEX: PHIA) ... ultrasound with Philips, industry leading Live 3D TEE, now ... with available Live 3D TEE and ICE will be ... EuroPCR, official meeting for the European Association of Percutaneous ... launch in 2012, Philips CX50 xMATRIX has been the ...
(Date:5/20/2013)... The Amazon rain forest, popularly known as the lungs of ... use carbon dioxide from the air to grow parts that ... away by the region,s plentiful rainfall. , Until recently ... the Amazon River and ended up deep in the ocean. ... exhale huge amounts of carbon dioxide though left open ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... Kimmel Award for Innovative Investigation on Monday, Nov. 5 at ... grant of a million dollars over five years. Taking ... the impulses that drive evolution. Living cells are, from this ... have all sorts of interesting consequences for many other molecules ...
... all" when it comes to weight loss through exercise, says ... Neil King, from QUT,s Institute of Health and Biomedical Innovation, ... with the University of Leeds in the UK, which has ... of Obesity. "When it comes to losing weight, a ...
... issue of BioScience describes the history and summarizes the ... surface and substrate. , Although more expensive to construct ... energy costs during a buildings lifetime and control storm-water ... structures are currently less common in the United States ...
Cached Biology News:Weizmann Institute scientists discover: A 'risk distribution law' for evolution 2Weight loss -- not one size fits all 2
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Recombinant Mouse MMP-9, CF...
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Biology Products: